CICC Capital Management Company Limited, a wholly-owned subsidiary of China International Capital Corporation Limited (CICC), has made a strategic investment between $238 million and $286 million in Concord Medical's subsidiary, Beijing Meizhong Jiahe Hospital Management Co., Ltd. The investors will hold 37.5 to 41.9 per cent of Meizhong Jiahe's equity after the investment.

Concord Medical Services Holdings Limited is a leading specialty hospital management solutions provider and operator of a network of radiotherapy and diagnostic imaging centers in China.

As the most important operating platform of Concord Medical in China, Meizhong Jiahe has been committed to investing in the operation of cancer diagnosis and treatment centers nationwide. It has developed into a nationwide hospital management group and a network of independent specialty cancer hospitals located in Beijing, Shanghai and Guangzhou, with an emphasis on high-end specialty cancer hospitals, including secondary specialty cancer hospitals and proton therapy treatment.

With the aim of ensuring technical training, promoting medical quality and strengthening hospital management, Meizhong Jiahe will provide high-quality medical services for patients.  Meizhong Jiahe is committed to becoming a top brand for Chinese specialty cancer hospitals by introducing international frontier medical research results, multidisciplinary treatment models and hospital management concepts.